Those With Mental Illness Have Higher Risk for Early Mortality
People living with any mental disorder have a shorter life expectancy than the general population.
General Psychiatry
Psychotherapy for Depression May Be Cost-Effective Over Time
For patients with major depressive disorder, neither second-generation antidepressants nor cognitive behavioral therapy offers consistently superior cost-effectiveness.
Is There a Link Between Drugs for Parkinson Disease and Gambling Disorders?
Pathological gambling was recently identified as a complication of Parkinson disease and its pharmacological treatment, especially high-dose dopaminergic agonists.
Text Messaging Intervention Aimed at Improving Parental Competence and Mental Health Literacy
MyTeen is a text message intervention that delivers advice and instruction to parents with a goal of improving parental competence, knowledge, and parent/adolescent communication.
Some Nutritional Supplements May Aid Mental Health Conditions
Nutrient supplements had good safety profiles and no known contraindications with psychiatric medications.
Comparing Pros, Cons of Antipsychotics for Multi-Episode Schizophrenia
Investigators compared the efficacy and tolerability of 32 oral antipsychotic agents for the acute treatment of multi-episode schizophrenia in adults.
Psychiatric Disorders May Up Risk for Bilateral Oophorectomy
Certain mental health conditions are associated with an increased risk for unnecessary bilateral oophorectomy for nonmalignant indications.
ADHD Medication Associated With Reduced Unintentional Injuries in Youth
ADHD medication use was associated with a lower risk for emergency department visits for unintentional injuries and traumatic brain injuries in both boys and girls at the population and individual levels.
Novel Mobile Application Shows Promise in Schizophrenia Self Management
The mobile application App4Independence may be a feasible solution to improve self-management in patients with schizophrenia spectrum disorders.
Potential First-in-Class Treatment for Tourette Syndrome Gets Fast Track Status
The Food and Drug Administration (FDA) has granted Fast Track designation to ecopipam (Emalex Biosciences), an investigational agent for the treatment of Tourette syndrome (TS).
